These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

485 related articles for article (PubMed ID: 32967612)

  • 1. Avoiding misdiagnosis: expert consensus recommendations for the suspicion and diagnosis of transthyretin amyloidosis for the general practitioner.
    Gertz M; Adams D; Ando Y; Beirão JM; Bokhari S; Coelho T; Comenzo RL; Damy T; Dorbala S; Drachman BM; Fontana M; Gillmore JD; Grogan M; Hawkins PN; Lousada I; Kristen AV; Ruberg FL; Suhr OB; Maurer MS; Nativi-Nicolau J; Quarta CC; Rapezzi C; Witteles R; Merlini G
    BMC Fam Pract; 2020 Sep; 21(1):198. PubMed ID: 32967612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expert consensus recommendations to improve diagnosis of ATTR amyloidosis with polyneuropathy.
    Adams D; Ando Y; Beirão JM; Coelho T; Gertz MA; Gillmore JD; Hawkins PN; Lousada I; Suhr OB; Merlini G
    J Neurol; 2021 Jun; 268(6):2109-2122. PubMed ID: 31907599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expert Consensus Recommendations for the Suspicion and Diagnosis of Transthyretin Cardiac Amyloidosis.
    Maurer MS; Bokhari S; Damy T; Dorbala S; Drachman BM; Fontana M; Grogan M; Kristen AV; Lousada I; Nativi-Nicolau J; Cristina Quarta C; Rapezzi C; Ruberg FL; Witteles R; Merlini G
    Circ Heart Fail; 2019 Sep; 12(9):e006075. PubMed ID: 31480867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for ATTR amyloidosis in the clinic: overlapping disorders, misdiagnosis, and multiorgan awareness.
    Nativi-Nicolau JN; Karam C; Khella S; Maurer MS
    Heart Fail Rev; 2022 May; 27(3):785-793. PubMed ID: 33609196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recommendations for the diagnosis and management of transthyretin amyloidosis with gastrointestinal manifestations.
    Nakov R; Suhr OB; Ianiro G; Kupcinskas J; Segal JP; Dumitrascu DL; Heinrich H; Mikolasevic I; Stojkovic-Lalosevic M; Barbov I; Sarafov S; Tournev I; Nakov V; Wixner J
    Eur J Gastroenterol Hepatol; 2021 May; 33(5):613-622. PubMed ID: 33394808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. World Heart Federation Consensus on Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM).
    Brito D; Albrecht FC; de Arenaza DP; Bart N; Better N; Carvajal-Juarez I; Conceição I; Damy T; Dorbala S; Fidalgo JC; Garcia-Pavia P; Ge J; Gillmore JD; Grzybowski J; Obici L; Piñero D; Rapezzi C; Ueda M; Pinto FJ
    Glob Heart; 2023; 18(1):59. PubMed ID: 37901600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis and management of transthyretin familial amyloid polyneuropathy in Japan: red-flag symptom clusters and treatment algorithm.
    Sekijima Y; Ueda M; Koike H; Misawa S; Ishii T; Ando Y
    Orphanet J Rare Dis; 2018 Jan; 13(1):6. PubMed ID: 29343286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transthyretin (ATTR) amyloidosis: clinical spectrum, molecular pathogenesis and disease-modifying treatments.
    Sekijima Y
    J Neurol Neurosurg Psychiatry; 2015 Sep; 86(9):1036-43. PubMed ID: 25604431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient and family experience with transthyretin amyloid cardiomyopathy (ATTR-CM) and polyneuropathy (ATTR-PN) amyloidosis: results of two focus groups.
    Rintell D; Heath D; Braga Mendendez F; Cross E; Cross T; Knobel V; Gagnon B; Turtle C; Cohen A; Kalmykov E; Fox J
    Orphanet J Rare Dis; 2021 Feb; 16(1):70. PubMed ID: 33557882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First Norwegian case of hereditary ATTR amyloidosis with a novel transthyretin variant.
    Lyng CS; Gude E; Hodt A; Knudsen EC
    Scand Cardiovasc J; 2023 Dec; 57(1):2174269. PubMed ID: 36734834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suspecting and diagnosing transthyretin amyloid cardiomyopathy (ATTR-CM) in India: An Indian expert consensus.
    Chander Mohan J; Dalal J; Chopra VK; Narasimhan C; Kerkar P; Oomman A; Ray Fcsi S; Sharma AR; Dougall P; Simon S; Verma Drm A; Radhakrishnan V
    Indian Heart J; 2022; 74(6):441-449. PubMed ID: 36410415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transthyretin Amyloid Cardiomyopathy-Current and Future Therapies.
    Yadav JD; Othee H; Chan KA; Man DC; Belliveau PP; Towle J
    Ann Pharmacother; 2021 Dec; 55(12):1502-1514. PubMed ID: 33685242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging Therapies for Transthyretin Amyloidosis.
    Tsoi MR; Lin JH; Patel AR
    Curr Oncol Rep; 2023 Jun; 25(6):549-558. PubMed ID: 36943555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A descriptive study of transthyretin amyloidosis in a tertiary hospital without a referral unit.
    Bueno Juana E; Gracia Gutiérrez A; Melero Polo J; Roteta Unceta-Barrenechea A; Andrés Gracia A; Lahuerta Pueyo C; Menao Guillén S; Revilla Martí P; Aibar Arregui MÁ
    Rev Clin Esp (Barc); 2022 Mar; 222(3):161-168. PubMed ID: 34563487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Genetic Testing in Transthyretin (ATTR) Cardiac Amyloidosis.
    Gopal DM; Ruberg FL; Siddiqi OK
    Curr Heart Fail Rep; 2019 Oct; 16(5):180-188. PubMed ID: 31520266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progress and challenges in the treatment of cardiac amyloidosis: a review of the literature.
    Adam RD; Coriu D; Jercan A; Bădeliţă S; Popescu BA; Damy T; Jurcuţ R
    ESC Heart Fail; 2021 Aug; 8(4):2380-2396. PubMed ID: 34089308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expert consensus on the monitoring of transthyretin amyloid cardiomyopathy.
    Garcia-Pavia P; Bengel F; Brito D; Damy T; Duca F; Dorbala S; Nativi-Nicolau J; Obici L; Rapezzi C; Sekijima Y; Elliott PM
    Eur J Heart Fail; 2021 Jun; 23(6):895-905. PubMed ID: 33915002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequency of hereditary transthyretin amyloidosis among elderly patients with transthyretin cardiomyopathy.
    Maestro-Benedicto A; Vela P; de Frutos F; Mora N; Pomares A; Gonzalez-Vioque E; Briceño A; Cabrera E; Cobo-Marcos M; Dominguez F; Gonzalez-Lopez E; Segovia J; Lara-Pezzi E; Garcia-Pavia P
    Eur J Heart Fail; 2022 Dec; 24(12):2367-2373. PubMed ID: 35999650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hereditary transthyretin-related amyloidosis is frequent in polyneuropathy and cardiomyopathy of no obvious aetiology.
    Skrahina V; Grittner U; Beetz C; Skripuletz T; Juenemann M; Krämer HH; Hahn K; Rieth A; Schaechinger V; Patten M; Tanislav C; Achenbach S; Assmus B; Knebel F; Gingele S; Skrahin A; Hartkamp J; Förster TM; Roesner S; Pereira C; Rolfs A
    Ann Med; 2021 Dec; 53(1):1787-1796. PubMed ID: 34658264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Neurological manifestations of ATTR amyloidosis].
    Pernice HF; Hahn K
    Inn Med (Heidelb); 2023 Sep; 64(9):848-854. PubMed ID: 37555967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.